Street Buzzing About New Hepatitis Treatment Developer
16:56 EDT 29 Jun 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
Despite a terrible day for the general markets on Thursday, shares of Medgenics Inc. (AMEX:MDGN) closed strong at $11.00 +1.01, +10.11% on rumors of positive developments ahead. The stock reached and then surpassed its previous 52-week high of $10.60 and ...
Other Sources for this Article
More From BioPortfolio on "Street Buzzing About New Hepatitis Treatment Developer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
